We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The NHS newborn blood spot (NBS) screening programme processes for ensuring a seamless and safe screening pathway.
Guidance for providers and commissioners to improve quality in the NHS newborn and infant physical examination screening programme.
Section (89A.01 - 89A.26) last updated: January 2023.
Decision on application for authorisation under UK REACH.
A report on the use of dual NAATs for chlamydia and gonorrhoea on samples collected for the National Chlamydia Screening Programme (NCSP).
Guidance on detecting gonorrhoea, including dual nucleic acid amplification tests (NAATs) for chlamydia and gonorrhoea.
The tool is a major advance in how the IPO performs patent searches.
PHE has undertaken rapid assessments of commercially provided diagnostic tests for SARS-CoV-2 nucleic acid detection with further evaluations ongoing.
Employment Appeal Tribunal Judgment of Mrs Justice Eady on 18 April 2024.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).